Poster presentation delivered at the Controlled Release Society (CRS) Annual Meeting, 2025.
Lipid-based formulations are a viable and scalable solution for oral bioavailability of peptides. Capsugel® Enprotect® capsules demonstrate high performance through in vitro and in vivo evaluations. Lonza CHI capsules can be customized to address specific needs. Innovaform® Accelerator can support your formulation development and collaborates with its customers to overcome drug delivery challenges through capsule innovation.
If you would like to discuss how we can support you with your drug development journey, please speak with our scientists at Innovaform® Accelerator.